Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 106

Sort by

Sort Order Select

Journal Articles

CRLF2 Expression in Mexicans with Acute Lymphoblastic Leukemia across the Age Spectrum

Héctor A. Martínez-Espinosa, Nereida Méndez-Ramírez, Julia Colunga Pedraza, Eli Fuentes-Chávez, Rosario Salazar-Riojas, Odra L. Martínez-González, Antonio Vega-Mateos, Oscar Gonzalez Llano, Ingrid López-Reyna, David Gomez-Almaguer, Andres Gomez-De Leon, Vanessa Treviño-Sordia, Roberto Solano-Texta

Blood (2023) 142 (Supplement 1): 6054.

https://doi.org/10.1182/blood-2023-188339

Published: 2023

Journal Articles

Exploring the Efficacy and Feasibility of Outpatient Blinatumomab Short Cycles in Pediatric Patients with Relapsed/Refractory B-ALL in LMIC: Preliminary Results

Julia Esther Colunga Pedraza, Samantha Rodriguez, Ingrid López-Reyna, Lucía Hernández Torres, Perla Rocio Colunga Pedraza, Valeria Fuentes, David Gomez-Almaguer, Yajaira Valentina Jimenez-Antolinez, Oscar Gonzalez Llano

Blood (2023) 142 (Supplement 1): 5813.

https://doi.org/10.1182/blood-2023-190271

Published: 2023

Journal Articles

The Doses of Post-Transplantation Cyclophosphamide in Haploidentical Stem Cell Allografts Can be Reduced

Juan Carlos Olivares-Gazca, María de Lourdes Pastelín-Martínez, Merittzel Abigail Montes-Robles, Moisés Manuel Gallardo-Pérez, Edgar Jared Hernández-Flores, Max Robles-Nasta, Daniela Sánchez-Bonilla, César Homero Gutierrez-Aguirre, Andres Gomez-De Leon, David Gomez-Almaguer, Guillermo José Ruiz-Delgado, Guillermo José Ruiz-Arguelles

Blood (2023) 142 (Supplement 1): 2173.

https://doi.org/10.1182/blood-2023-181489

Published: 2023

Journal Articles

Optimizing Resources: Low-Dose Nivolumab Combinations in the Management of Relapsed/Refractory Hodgkin Lymphoma, a Real-World Experience

Héctor Alejandro Vaquera Alfaro, Zulia Guzman-Martínez, Antonio Vega-Mateos, Yadith Karina Lopez-Garcia, Ana Cristina Tejada Vasquez, Gerardo Garcia-Salas, César Homero Gutierrez-Aguirre, Olga Cantu, David Gomez-Almaguer, Perla R. Colunga-Pedraza

Blood (2023) 142 (Supplement 1): 1711.

https://doi.org/10.1182/blood-2023-188171

Published: 2023

Journal Articles

Disparities in Phase 3 Leukemia Trials from the Last Decade: A Long Way to Go

Andres Noyola-Perez, Alejandra J. Osuna-Corrales, Manali I. Patel, Jorge Cortes, Lillian Sung, Juan C. Angulo-Lozano, Perla R. Colunga-Pedraza, David Gomez-Almaguer, Guillermo José Ruiz-Arguelles, Andres Gomez-De Leon

Blood (2023) 142 (Supplement 1): 494.

https://doi.org/10.1182/blood-2023-189576

Published: 2023

Journal Articles

Real-World Data on the Clinical Features, Therapy Patterns and Outcomes of 651 Elderly Patients with Diffuse Large B-Cell Lymphoma in Latin America: A Study from the Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL)

Blood (2023) 142 (Supplement 1): 1748.

https://doi.org/10.1182/blood-2023-187049

Published: 2023

Journal Articles

Validating the Halp Score (Hemoglobin,Albumin, Lymphocytes, and Platelets) and the Neutrophil/Lymphocyte Ratio ( NLR ) As Prognostic Factors for Overall Survival in Patients with Diffuse Large B-Cell Lymphoma. Retrospective Analysis By the Grupo De Estudio De Latino America De Linfoproliferativos (GELL)

Blood (2023) 142 (Supplement 1): 1757.

https://doi.org/10.1182/blood-2023-188265

Published: 2023

Journal Articles

Light Chain Amyloidosis Plasma Cells Show Specific Chromatin Accessibility and Transcriptome

Blood (2023) 142 (Supplement 1): 4676.

https://doi.org/10.1182/blood-2023-185614

Published: 2023

Journal Articles

Outpatient Low-Dose Venetoclax Plus Azacitidine Vs. Intensive Chemotherapy for Newly Diagnosed Fit Patients with Acute Myeloid Leukemia in a Limited Resource Setting

Yadith Karina Lopez-Garcia, Fernando De La Garza, Gerardo Alexis De la Rosa-Flores, Edgar Ulises Coronado Alejandro, Antonio Vega-Mateos, Ana Cristina Tejada Vasquez, Gerardo Garcia-Salas, Valeria García-Zárate, Perla R. Rocio Colunga-Pedraza, David Gomez-Almaguer, Andres Gomez-De Leon

Blood (2023) 142 (Supplement 1): 1529.

https://doi.org/10.1182/blood-2023-188088

Published: 2023

Journal Articles

Uncovering the Cis-Regulatory Program of Early Human B-Cell Commitment and Its Implications in the Pathogenesis of B-Cell Acute Lymphoblastic Leukemia

Blood (2023) 142 (Supplement 1): 4044.

https://doi.org/10.1182/blood-2023-185799

Published: 2023

Journal Articles

Combined Single-Cell and Spatial Transcriptomics Unveil the Complex Organization of the Non-Immune Human Bone Marrow Microenvironment during Aging

Blood (2023) 142 (Supplement 1): 2706.

https://doi.org/10.1182/blood-2023-179730

Published: 2023

Journal Articles

Lost and Found: A Mixed Methods Study on Treatment Abandonment in Acute Leukemia

Ana Cristina Tejada Vasquez, Eliezer Gomez, Fernando De La Garza, Edgar Ulises Coronado Alejandro, Carlos De La Cruz-De La Cruz, Valeria García-Zárate, Anna Cecilia Rodriguez-Zuñiga, Alexia Sánchez, David Gomez-Almaguer, Andres Gomez-De Leon

Blood (2023) 142 (Supplement 1): 2439.

https://doi.org/10.1182/blood-2023-189645

Published: 2023

Journal Articles

Unlocking Global Potential: Education and Funding Opportunities for International Trainees in Hematology

Lourdes Gil-Flores, Emilia Ramos-Barrera, Andrea Flores-Díaz, Lillian Sung, David Gomez-Almaguer, Andres Gomez-De Leon

Blood (2023) 142 (Supplement 1): 3699.

https://doi.org/10.1182/blood-2023-182261

Published: 2023

Journal Articles

CYP Inhibition and Low-Dose Dasatinib for Chronic Myeloid Leukemia: Preliminary Results of a Promising, Cost-Effective Treatment Option

Juan Francisco Barrios Ruiz, Fernando De La Garza, Victor Mingura Ledezma, Olga Cantu, Ana Cristina Tejada Vasquez, David Gomez-Almaguer, Perla R. Rocio Colunga-Pedraza

Blood (2023) 142 (Supplement 1): 5744.

https://doi.org/10.1182/blood-2023-188215

Published: 2023

Journal Articles

Autologous HSCT for Multiple Sclerosis Should be Done Early in the Course of the Disease

María de Lourdes Pastelín-Martínez, Moisés Manuel Gallardo-Pérez, Andres Gomez-De Leon, Juan Carlos Olivares-Gazca, Edgar Jared Hernández-Flores, Daniela Sánchez-Bonilla, Merittzel Abigail Montes-Robles, Max Robles-Nasta, Guillermo Ocaña-Ramm, Silvia Soto-Olvera, David Gomez-Almaguer, Guillermo José Ruiz-Delgado, Guillermo José Ruiz-Arguelles

Blood (2023) 142 (Supplement 1): 3593.

https://doi.org/10.1182/blood-2023-181433

Published: 2023

Journal Articles

Ponatinib Versus Imatinib in Patients with Newly Diagnosed Ph+ ALL: Subgroup Analysis of the Phase 3 Phallcon Study

Blood (2023) 142 (Supplement 1): 2871.

https://doi.org/10.1182/blood-2023-179537

Published: 2023

Journal Articles

Validating the Systemic Inmmune-Inflamation Index (SII) As a Prognostic Biomarker of Overall Survival in Diffuse Large B-Cell Lymphoma: A Retrospective Analyses By the Gruppo De Estudio Latinoamericano De Linfoproliferativos (GELL)

Blood (2023) 142 (Supplement 1): 1775.

https://doi.org/10.1182/blood-2023-188015

Published: 2023

Journal Articles

Comprehensive Characterization of the Bone Marrow Microenvironment Transcriptional Remodeling in the Progression from MGUS to Smoldering and Multiple Myeloma

Blood (2023) 142 (Supplement 1): 88.

https://doi.org/10.1182/blood-2023-178534

Published: 2023

Journal Articles

Spatial Transcriptomics Unveils Novel Potential Mechanisms of Disease in a MI cγ1 Multiple Myeloma in vivo Model

Blood (2023) 142 (Supplement 1): 4076.

https://doi.org/10.1182/blood-2023-181643

Published: 2023

Journal Articles

Capizzi Vs HDMTX in the Intermediate Maintenance Phase in Patients with Intermediate-Risk ALL in a 3rd Level Hospital in Northeastern Mexico

Valeria Fuentes, Yajaira Valentina Jimenez-Antolinez, Ginna Mariana Romero-Jacobo, Paulina Garcia - Maldonado, Juan Pablo Ruiz-Padilla, Samantha Carolina Rodriguez- Miranda, Jorge Federico Marcos-Garcia, Julia Esther Colunga Pedraza, David Gomez-Almaguer, Oscar Gonzalez Llano

Blood (2023) 142 (Supplement 1): 5883.

https://doi.org/10.1182/blood-2023-190990

Published: 2023

NARROW

CRLF2 Expression in Mexicans with Acute Lymphoblastic Leukemia across the Age Spectrum

Exploring the Efficacy and Feasibility of Outpatient Blinatumomab Short Cycles in Pediatric Patients with Relapsed/Refractory B-ALL in LMIC: Preliminary Results

The Doses of Post-Transplantation Cyclophosphamide in Haploidentical Stem Cell Allografts Can be Reduced

Optimizing Resources: Low-Dose Nivolumab Combinations in the Management of Relapsed/Refractory Hodgkin Lymphoma, a Real-World Experience

Disparities in Phase 3 Leukemia Trials from the Last Decade: A Long Way to Go

Real-World Data on the Clinical Features, Therapy Patterns and Outcomes of 651 Elderly Patients with Diffuse Large B-Cell Lymphoma in Latin America: A Study from the Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL)

Light Chain Amyloidosis Plasma Cells Show Specific Chromatin Accessibility and Transcriptome

Outpatient Low-Dose Venetoclax Plus Azacitidine Vs. Intensive Chemotherapy for Newly Diagnosed Fit Patients with Acute Myeloid Leukemia in a Limited Resource Setting

Uncovering the Cis-Regulatory Program of Early Human B-Cell Commitment and Its Implications in the Pathogenesis of B-Cell Acute Lymphoblastic Leukemia

Combined Single-Cell and Spatial Transcriptomics Unveil the Complex Organization of the Non-Immune Human Bone Marrow Microenvironment during Aging

Lost and Found: A Mixed Methods Study on Treatment Abandonment in Acute Leukemia

Unlocking Global Potential: Education and Funding Opportunities for International Trainees in Hematology

CYP Inhibition and Low-Dose Dasatinib for Chronic Myeloid Leukemia: Preliminary Results of a Promising, Cost-Effective Treatment Option

Autologous HSCT for Multiple Sclerosis Should be Done Early in the Course of the Disease

Ponatinib Versus Imatinib in Patients with Newly Diagnosed Ph+ ALL: Subgroup Analysis of the Phase 3 Phallcon Study

Validating the Systemic Inmmune-Inflamation Index (SII) As a Prognostic Biomarker of Overall Survival in Diffuse Large B-Cell Lymphoma: A Retrospective Analyses By the Gruppo De Estudio Latinoamericano De Linfoproliferativos (GELL)

Comprehensive Characterization of the Bone Marrow Microenvironment Transcriptional Remodeling in the Progression from MGUS to Smoldering and Multiple Myeloma

Spatial Transcriptomics Unveils Novel Potential Mechanisms of Disease in a MI cγ1 Multiple Myeloma in vivo Model

Capizzi Vs HDMTX in the Intermediate Maintenance Phase in Patients with Intermediate-Risk ALL in a 3rd Level Hospital in Northeastern Mexico

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only